BARCLAYS PLC - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 143 filers reported holding PLIANT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,236
+154.1%
244,266
+165.3%
0.00%
+200.0%
Q2 2023$1,667
+430.9%
92,076
+681.6%
0.00%
Q1 2023$314
-38.7%
11,781
-55.6%
0.00%
Q4 2022$512
-99.6%
26,515
+373.8%
0.00%
Q3 2022$117,000
+25.8%
5,596
-51.8%
0.00%
Q2 2022$93,000
-14.7%
11,609
-25.0%
0.00%
Q1 2022$109,00015,4830.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 1,839,160$35,550,96327.86%
TRV GP IV, LLC 2,132,867$41,228,31917.53%
CHI Advisors LLC 3,169,892$61,274,01216.32%
GREAT POINT PARTNERS LLC 1,322,870$25,571,0775.01%
VR Adviser, LLC 1,080,000$20,876,4003.52%
Redmile Group, LLC 3,878,599$74,973,3193.07%
Casdin Capital, LLC 1,675,000$32,377,7502.51%
Fernwood Investment Management, LLC 304,573$5,887,3962.44%
Cheyne Capital Management (UK) LLP 66,144$1,278,5642.23%
First Light Asset Management, LLC 1,057,881$20,448,8401.90%
View complete list of PLIANT THERAPEUTICS INC shareholders